Understanding how price transparency tools can help patients with multiple health conditions manage medication costs
Official title: Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
Funded at Duke University · NIH-11000274 · Data updated 2026-11-12
This study is looking at how tools that show medication prices can help doctors support older adults with multiple health issues in paying for their medicines, making it easier for them to stick to their treatment plans and stay healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | January 1, 2023 |
| Project end | December 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $181,733 |
| NIH project number | 5K23AG076889-03 |
| Project ID | NIH-11000274 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults with multiple chronic conditions who struggle with medication adherence due to cost concerns.
✕Less likely to help
Patients who do not have multiple health conditions or those who do not face financial barriers to medication may not benefit from this research.
What this research studies
This research investigates how price transparency tools can assist primary care providers in helping older adults with multiple health conditions afford their medications. By evaluating the use of these tools within a large academic health system, the study aims to determine their effectiveness in improving medication adherence and overall disease management. The research will focus on how clinicians can access and utilize out-of-pocket medication costs at the point of prescribing, potentially leading to better patient outcomes. The study will also assess the acceptability and feasibility of these tools among healthcare providers and patients.
Why it matters
Potential benefit: If successful, this research could lead to improved medication adherence and better health outcomes for patients with multimorbidity by making medication costs more transparent.
How similar studies have gone: Previous research has shown that interventions aimed at improving medication adherence through cost transparency can be effective, suggesting a promising avenue for this study.
Where this research is happening
-
Duke University
Durham, United States Active
Researchers
- Principal investigator: Sloan, Caroline Ellen — Duke University
- Study coordinator: Sloan, Caroline Ellen
Related research
Other NIH-funded projects on the same topics.
-
Integrated Heart Health: A HEARTS-based approach to hypertension and diabetes in Guatemala
A study tests a team-based, stepwise care model to improve blood pressure and blood sugar control for people with both hypertension and diabetes in Guatemala.
-
M-CaRE: Mobile clinics and a smart heart-lung care tool for multimorbidity
A mobile, multilingual tool plus community health workers will help screen and manage high blood pressure and COPD in diverse adult patients, especially in underserved areas.
-
Alcohol and HIV interaction driving lung and liver damage through cell signals
This program explores how alcohol worsens lung and liver problems in people with HIV by affecting cell signals that travel between organs.
-
Understanding why patients with blood cancers start and stick with oral cancer medicines
A study to learn what helps or hinders Black patients with blood cancers in starting and continuing their prescribed oral cancer medicines.
-
Incentives and Anchoring to Improve Long-term HIV Medication Adherence
A study tests a simple, daily habit plan combined with friendly reminders and small rewards to help people living with HIV take their ART pills on time.
-
WeCare: a combined mental health and HIV medication support program for high-risk men
A patient-friendly program called WeCare aims to support mental health and improve adherence to HIV meds among high-risk men in settings with limited resources.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.